Boylu Ugur, Horasanli Kaya, Tanriverdi Orhan, Kendirci Muammer, Gumus Eyup, Miroglu Cengiz
Department of Urology, Sisli Etfal Teaching and Research Hospital, 34377, Sisli, Istanbul, Turkey.
Pediatr Surg Int. 2006 Apr;22(4):375-9. doi: 10.1007/s00383-006-1660-5. Epub 2006 Mar 4.
We evaluated the bone mineral density (BMD) after ileal augmentation cystoplasty in a group of children with and without myelomeningocele. Between 1996 and 2003, eight patients with neurogenic bladder and seven patients with non-neurogenic bladder underwent augmentation ileocystoplasty. Preoperative and postoperative serum creatinine and electrolytes were measured. All patients underwent clinical evaluation, supine height measurement, blood gas analysis, and BMD measurement using a dual energy X-ray absorptiometry (DEXA) postoperatively. BMD was measured at L1-L4 and femoral neck, and compared to age- and sex-matched population. Follow-up time was calculated from the day of surgery to the day of DEXA performance. A total of eight boys and seven girls with the mean age of 10.2 +/- 4.1 years were evaluated with respect to BMD measurement. Mean age was 9.8 years in neurogenic group and 10.5 in non-neurogenic group. Mean follow-up was 728 and 616 days in neurogenic and non-neurogenic groups, respectively. There were no significant differences between ages, follow-up times, preoperative and postoperative creatinine levels, pH and bicarbonate values, and supine heights. Mean BMD at L1-L4 was 55.7% in neurogenic group and 83.8% in non-neurogenic group. There was a statistically significant difference between the two groups (P = 0.02). Mean BMD at femoral neck was 72% in neurogenic group and 86.2% in non-neurogenic group. The difference was also statistically significant (P = 0.028). After augmentation ileocystoplasty, the BMD in early postoperative period of patients with myelomeningocele is lower than the patients with non-neurogenic neurogenic bladder, which have the same clinical characteristics except the neurologic pathology. In the light of our findings and the reported literature data as well, we may claim that BMD decrease after augmentation ileocystoplasty depends more on the underlying neurologic pathology and its locomotor consequences rather than the enterocystoplasty itself.
我们评估了一组患有和未患有脊髓脊膜膨出症的儿童在回肠扩大膀胱成形术后的骨矿物质密度(BMD)。1996年至2003年间,8例神经源性膀胱患者和7例非神经源性膀胱患者接受了回肠扩大膀胱成形术。测量术前和术后的血清肌酐和电解质。所有患者术后均接受临床评估、仰卧位身高测量、血气分析以及使用双能X线吸收法(DEXA)进行骨矿物质密度测量。在L1-L4和股骨颈处测量骨矿物质密度,并与年龄和性别匹配的人群进行比较。随访时间从手术日计算至进行DEXA检查之日。共有8名男孩和7名女孩接受了骨矿物质密度测量评估,平均年龄为10.2±4.1岁。神经源性组的平均年龄为9.8岁,非神经源性组为10.5岁。神经源性组和非神经源性组的平均随访时间分别为728天和616天。年龄、随访时间、术前和术后肌酐水平、pH值和碳酸氢盐值以及仰卧位身高之间均无显著差异。神经源性组L1-L4处的平均骨矿物质密度为55.7% ,非神经源性组为83.8% 。两组之间存在统计学显著差异(P = 0.02)。神经源性组股骨颈处的平均骨矿物质密度为72% ,非神经源性组为86.2% 。差异同样具有统计学显著性(P = 0.028)。在回肠扩大膀胱成形术后,除神经病理学外具有相同临床特征的脊髓脊膜膨出症患者术后早期的骨矿物质密度低于非神经源性膀胱患者。根据我们的研究结果以及报道的文献数据,我们可以认为回肠扩大膀胱成形术后骨矿物质密度降低更多地取决于潜在的神经病理学及其运动后果,而非肠膀胱成形术本身。